action of glp-1 agonist Frontiers Mechanism of action of GLP-1
Description
Pregnancy contraindicates weight loss GLP 1 medications entirely
Supported by emerging clinical evidence
It is a small-molecule oral GLP-1 receptor agonist developed by Eli Lilly, the same company behind tirzepatide
doi: 10.1016/j.clinme.2025.100298 [DOI] [PMC free article] [PubMed] [Google Scholar] 226.Price SAL, Nankervis A
Dungan & DeSantis, 2026)
Trulicity FDA Approval History , (Jan 28, 2021)
